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Abstract 
Purpose: Tracer-kinetic models can be used for the quantitative assessment of contrast-enhanced MRI 
data. However, the model-fitting can produce unreliable results due to the limited data acquired and the 
high noise levels. Such problems are especially prevalent in myocardial perfusion MRI leading to the 
compromise of constrained numerical deconvolutions and segmental signal averaging being commonly 
used as alternatives to the more complex tracer-kinetic models.   
Methods: In this work, the use of hierarchical Bayesian inference for the parameter estimation is 
explored. It is shown that with Bayesian inference it is possible to reliably fit the two-compartment 
exchange model to perfusion data. The use of prior knowledge on the ranges of kinetic parameters and 
the fact that neighbouring voxels are likely to have similar kinetic properties combined with a Markov 
chain Monte Carlo based fitting procedure significantly improves the reliability of the perfusion 
estimates with compared to the traditional least-squares approach. The method is assessed using both 
simulated and patient data.  
Results: The average (standard deviation) normalised mean square error for the distinct noise 
realisations of a simulation phantom falls from 0.32 (0.55) with the least-squares fitting to 0.13 (0.2) 
using Bayesian inference. The assessment of the presence of coronary artery disease based purely on 
the quantitative MBF maps obtained using Bayesian inference matches the visual assessment in all 24 
slices. When using the maps obtained by the least-squares fitting, a corresponding assessment is only 
achieved in 16/24 slices. 
Conclusion: Bayesian inference allows a reliable, fully automated and user-independent assessment of 
myocardial perfusion on a voxel-wise level using the two-compartment exchange model.   
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1. Introduction 
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can be used for the non-invasive 
assessment of myocardial perfusion (Chiribiri et al., 2009; Jaarsma et al., 2012; Nagel et al., 2003). 
According to recent clinical guidelines, it is indicated for the assessment of patients at risk of coronary 
artery disease (CAD) (Montalescot et al., 2013; Windecker et al., 2014) and has been extensively 
validated against the reference standard, fractional flow reserve (Li et al., 2014). Currently, the clinical 
evaluation of such image series is performed visually. The spatial and temporal distribution of contrast 
agent in the myocardium can identify myocardial ischaemia and provide insight into the presence and 
severity of stenosis. Some of the main limitations of this visual assessment are the difficulty of 
interpreting the images (Villa et al., 2018) and the underestimation of the ischaemic burden in patients 
with multivessel CAD (Patel et al., 2010). This has led to myocardial perfusion examinations only being 
routinely performed in highly experienced centres. Quantitative perfusion analysis has been proposed 
as a more reproducible and user-independent alternative of visual assessment and has been shown to 
have a good diagnostic accuracy and prognostic value (Hsu et al., 2018; Knott et al., 2019; Sammut et 
al., 2017).  
The quantification of myocardial perfusion from DCE-MRI data is achieved by applying tracer-kinetic 
models to track the passage of the contrast agent from the left ventricle (LV) to the myocardium and 
infer the kinetic model parameters, such as myocardial blood flow (MBF) (Broadbent et al., 2013; Hsu 
et al., 2018; M Jerosch-Herold et al., 1998; Kellman et al., 2017; Wilke et al., 1997). However, there 
has been questions raised on the reliability of the quantitative parameters values that are estimated from 
DCE-MRI data due to the complexity of the models relative to the observed data (Buckley, 2002). This 
had led to the use of simplified models, such as the Fermi function (Jerosch-Herold et al., 1998; Wilke 
et al., 1997) or concentration curves that have been averaged over a region of the myocardium in order 
to boost the signal-to-noise ratio (SNR). A recent editorial by Axel (Axel, 2018) calls for improved 
quantitative methods, in particular more robust quantitative values.   
Larsson et al. (Larsson et al., 1996) showed that they could not reliably fit the five parameters needed 
for the tracer-kinetic modelling to the observed data, using least-squares fitting. As shown in the 
comparative study of Schwab et al. (Schwab et al., 2015), they were able to achieve reliable 
quantification with relatively simpler models, such as a Fermi-constrained deconvolution, but not with 
the multi-compartment exchange models. Broadbent et al. (Broadbent et al., 2013) report failed fitting 
in 10% of cases (despite using concentration curves that have been averaged over a segment of the 
myocardium) and Likhite et al. (Likhite et al., 2017) also reported failed fittings to simulated data which 
is simplistic with respect to the patient data.  
Some of the reasons behind the reported difficulties in the model fitting include that such parameter 
estimation, or non-linear regression, problems are known to get stuck in local optima (Dikaios et al., 
2017). As a result, even though the model-based concentration curves may well match the observed 
data, the reported parameters may be far from the true values. It has further been shown that the model 
parameters are correlated (Romain et al., 2017) and thus there are multiple distinct combinations of 
parameters that give outputs that are indistinguishable at the observed noise level.  Also, as is typical 
with non-linear optimisations, the parameter estimates are highly sensitive to the initial conditions of 
the optimisation and the specific noise present in the data. A further limitation is that this non-linear 
least-squares fitting does not explicitly deal with the uncertainty in the estimated kinetic parameters.   
In conclusion, there is need for an improved methodology to allow robust and reproducible estimation 
of the kinetic model parameters including, but not limited to, MBF. In this work, we develop and 
evaluate a framework to robustly infer the kinetic model parameters from the observed imaging data 
based on hierarchical Bayesian probabilistic modelling. This approach is validated using simulation 
phantoms where gold standard kinetic parameters are known and subsequently further testing on clinical 
data is reported. 
  
2. Background 
2.1 Tracer-kinetic models 
The tracer-kinetic models as presented in the literature (Ingrisch and Sourbron, 2013; Sourbron and 
Buckley, 2013) model the perfusion unit (a single voxel or segment) as a system with two interacting 
compartments - the plasma and the interstitium. These models give a pair of coupled differential 
equations which describe the evolution of the contrast agent as a non-linear function of physiological 
parameters, such as MBF.  In this work, the tracer-kinetic model analysis was performed by fitting a 
two-compartment exchange model (2CXM) (Jerosch-herold, 2010; Sourbron and Buckley, 2013) to the 
observed concentration curves 
                                       𝑣𝑝
𝑑𝐶𝑝(𝑡)
𝑑𝑡
=
𝐹𝑏
1−𝐻𝑐𝑡
(𝐶𝐴𝐼𝐹(𝑡) − 𝐶𝑝(𝑡)) + 𝑃𝑆 (𝐶𝑒(𝑡) − 𝐶𝑝(𝑡))                                  (1) 
                                        𝑣𝑒
𝑑𝐶𝑒(𝑡)
𝑑𝑡
= 𝑃𝑆 (𝐶𝑝(𝑡) − 𝐶𝑒(𝑡)).                                                             (2) 
In (1) and (2), 𝐶𝑝(𝑡) and 𝐶𝑒(𝑡) are the concentration of contrast agent in the plasma and interstitial 
space at time 𝑡, respectively (in units of M). 𝐶𝐴𝐼𝐹(𝑡), the arterial input function (AIF), is the assumed 
input to the system that is being modelled (also in units of M). In myocardial perfusion quantification 
this is sampled from the LV. 𝐹𝑏 is the MBF (mL/min/mL), 𝑣𝑝 is the fractional plasma volume 
(dimensionless), 𝑣𝑒 is the fractional interstitial volume (dimensionless) and 𝑃𝑆 is the permeability-
surface area product (mL/min/mL). 𝐻𝑐𝑡 is the haematocrit value (dimensionless).  
This model has the benefit over other simpler models in that it resolves directly for MBF. The simpler 
models, such as those presented by Tofts et al. (Tofts and Kermode, 1991), only allow the estimation 
of the 𝐾𝑡𝑟𝑎𝑛𝑠 parameter which can be influenced by either MBF or the extraction fraction. The Fermi 
function (Jerosch-herold et al., 1998; Wilke et al., 1997) does resolve for MBF but not other kinetic 
parameters and the model is not physiologically motivated.  
The solution to this system is then given as:  
                                                             𝐶𝚯(𝑡) = 𝑅𝐹(𝑡, 𝚯) ∗ 𝐶𝐴𝐼𝐹(𝑡 − 𝜏0)                                                          (3) 
with the analytic form of the residue function 𝑅𝐹 presented in the appendix. 𝚯 = (Fp, vp, ve, PS)
T
 and 
𝜏0 is the time delay term which accounts for the fact that the contrast agent does not move 
instantaneously from the left ventricle to the myocardial tissue. This is an unknown parameter that must 
also be estimated. The concentration that is observed in the MRI experiment is the contribution from 
both compartments and is given as: 𝐶(𝑡) = 𝑣𝑝 ⋅ 𝐶𝑝(𝑡) + 𝑣𝑒 ⋅ 𝐶𝑒(𝑡). 
2.2 Non-linear regression 
The standard technique to estimate the model parameters uses a least-squares method. Given the 
observed contrast agent concentrations 𝒚 = (𝑦(𝑡0), 𝑦(𝑡1), … , 𝑦(𝑡𝑁−1))
𝑇
, it is assumed that: 𝑦(𝑡𝑗) =
 𝐶𝚯(𝑡𝑗) + 𝜖𝑗 where 𝜖𝑗  are the error terms and comprise of both noise and other sources of error, such as 
motion. The estimation of the parameters is then to find the 𝜣 which minimises the sum of squared 
errors cost function 𝜒2: 
                              ?̂? =  𝑎𝑟𝑔𝑚𝑖𝑛𝜣𝜒
2(𝜣) =  𝑎𝑟𝑔𝑚𝑖𝑛𝜣
1
𝑁
∑ (𝐶𝚯(𝑡𝑗) − 𝑦(𝑡𝑗))
2
𝑁−1
𝑗=0
                      (4) 
Under the assumption that the error terms come from independent and identically distributed Gaussian 
distribution this is equivalent to the maximum likelihood estimate as it maximises the likelihood 
function 𝑝(𝐲|𝚯).  
As previously discussed, this technique can break down in the case where the cost function has multiple 
local minima. That is, there are multiple values of 𝜣 that produce similar model output. If this is the 
case, the values of the parameters estimated may depend strongly on the initial conditions of the 
optimisation and be far from the true values. Furthermore, in vivo, the time delay parameter 𝜏0 can 
introduce further local minima. 
An example of such a cost function is shown in Fig. 1. It is seen that when noise is added, two local 
optima emerge, neither of which correspond to the true parameter values. The optimisation will 
converge to one of these depending on its initial conditions. In other cases it is possible for the cost 
functions to possess long flat valleys where optimisation may stop due to the update being less than the 
required tolerance leading to unreliable parameter estimates. This cost function was constructed using 
simulated data and can possess further local optima due to the complex errors and physiology seen in 
patient data. Additionally, as shown by Sommer and Schmid (Sommer and Schmid, 2014), the analytic 
form of the residue function 𝑅𝐹, which is the sum of two exponentially decaying components, can lead 
to an identifiability problem when the two exponents are too similar or when the contribution of one 
compartment vanishes which can further reduce the reliability of the parameter estimates. 
Figure 1. 
 
 
An example of a cost function created using simulated data, on the left in the noise-free case and on the 
right with an application realistic SNR of 15. This image is constructed by taking the minimum intensity 
projection over the three parameters 𝑣𝑝, 𝑣𝑒 and 𝑃𝑆 to allow the visualisation of the 5-dimensional 
surface as a function of 𝐹𝑏 and 𝜏0. The true parameter values used in the forward simulation are 𝐹𝑏 =
1.0, 𝑣𝑝 = 0.08, 𝑣𝑒 = 0.16, 𝑃𝑆 = 0.4, 𝜏0 = 0.1. In the noise-free (left) case the cost function has a global 
minimum which corresponds to the true parameter values (yellow dot). In the presence of noise (right) 
it is seen that there are two local optima, neither of which correspond to the true parameter values. The 
optimisation will converge to one of these depending on its initial conditions. The yellow circle is the 
position of the true minimum of the cost function and the two cross symbols are the positions of the two 
local minima. 
 
Fig. 2 shows two myocardial tissue curves that have been simulated using the same parameters, with 
the only difference being the realisation of the Rician noise that is added. This could be interpreted as 
being two curves from neighbouring voxels with the same underlying physiology. In this example it is 
seen how the traditional non-linear regression algorithms can yield vastly different fits, with the two 
fitted MBF values (𝐹𝑏) being different by a factor of two despite being simulated with the same kinetic 
parameters. 
Figure 2. 
  
For the same arterial input function AIF (red curves) and the same ground-truth parameters (𝐹𝑏 =
3.6, 𝑣𝑝 = 0.08, 𝑣𝑒 = 0.16, 𝑃𝑆 = 0.5) the two blue curves are simulated. Their only difference being the 
Rician noise realisation. A comparison of the two fits shows a difference of a factor of two in the 
computed MBF. This could vastly change the patients’ diagnosis.   
 
2.3 Bayesian parameter estimation 
The aforementioned maximum-likelihood approach assumes that there is one true value of the 
parameter and computes a point estimate of this. Conversely, Bayesian estimation treats the parameters 
as random variables and approximates their posterior distribution.  This hence allows computation of 
the expected value of the parameter. The variance of the distribution also allows an expression of 
confidence in the value of the parameter estimate. 
It is assumed that the observed data 𝑦 at each time point 𝑡𝑗, 𝑗 = 0, … , 𝑁 − 1 comes from the model with 
some Gaussian error with variance 𝜎𝑗
2 such that: 𝑦(𝑡𝑗) ~𝒩(𝐶𝚯(𝑡𝑗), 𝜎𝑗
2). To then examine to model 
parameters given observed data, the posterior distribution 𝑝(𝚯|𝒚) is required. The posterior distribution 
can be obtained through the application of Bayes’ theorem 
                                               𝑝(𝚯|𝒚) =  
𝑝(𝐲|𝚯) ⋅ 𝑝(𝚯)
∫ 𝑝(𝐲|𝚯) ⋅ 𝑝(𝚯)
 
𝚯
𝑑𝚯
 ∝  𝑝(𝐲|𝚯) ⋅ 𝑝(𝚯).                                       (5) 
The term 𝑝(𝚯) is the prior probability of the parameters. It is common to assume that the parameters 𝜃𝑖 
are independent and so 𝑝(𝚯) is the product of the prior distributions over the individual parameters, 𝜃𝑖. 
In general, the posterior distribution is not analytically tractable and must be approximated using 
Markov chain Monte Carlo (MCMC) sampling. Through (5), it is possible to compute samples which 
are proportional to the posterior distribution and MCMC sampling utilises these samples to construct a 
Markov chain with a stationary distribution equal to the posterior distribution. It does this using a 
proposal distribution which is used to propose, randomly, how to move in parameter space and an 
acceptance rule which is used to decide whether to accept the proposed move or not, based on the 
information from the likelihood and the prior information. An introduction to the use of Bayesian 
modelling for non-linear regression problems is given in the book of Seber and Wild (Seber and Wild, 
1989). 
2.3.1 Hierarchical Bayesian modelling 
Quantitative myocardial perfusion MRI is a natural application for the use of hierarchical Bayesian 
modelling. In this modelling approach, the prior probability distribution is not governed by fixed 
hyperparameters but rather hyperparameters 𝛂 which are described by a further probability distribution, 
i.e a hyperprior 𝑝(𝛂). Hence, 𝚯 in (5) is now dependent on these hyperparameters and (5) becomes: 
                                                   𝑝(𝚯, 𝛂|𝒚) ∝  𝑝(𝐲|𝚯, 𝛂) ⋅ 𝑝(𝚯|𝛂) ⋅ 𝑝(𝛂)                                                      (6) 
This approach is useful when the data is structured into distinct but not entirely unrelated groups. This 
is referred to as partial pooling, as opposed to complete pooling (use of one fixed prior distribution) or 
no pooling (use of different priors for each group). For example, in a stress perfusion MRI, these distinct 
groups would be healthy and diseased tissues. If the same prior knowledge was used for both groups, 
then it would lead to an averaging effect over these regions. Hierarchical modelling is thus an attractive 
compromise between treating the groups equivalently and having completely independent models. 
2.3.2 Generalised Gaussian Markov random field prior 
In addition to prior distributions on the kinetic parameters, it is possible to incorporate spatial prior 
knowledge. This enforces smoothness in the spatial domain and it motivated by the idea that 
neighbouring voxels should exhibit similar kinetic properties. In particular, in this application, a 
generalised Gaussian Markov random field prior is suitable. Mathematically, this is equivalent to 
putting prior distributions on the differences between parameters in neighbouring voxels that have zero 
mean:  
                                                𝐩(𝚯𝑖|𝚯𝑗, 𝜈𝑖,𝑗) ∝ exp (−
𝜈𝑖,𝑗
2
 ‖𝐖 (𝚯𝑖 − 𝚯𝑗)‖𝑝
𝑝
) , if 𝑗~𝑖                               (7) 
where 𝑗~𝑖 if 𝑗 and 𝑖 are neighbouring voxels and 1 ≤ 𝑝 ≤ 2. The use of 𝑝 = 1 corresponds to the 
Laplace distribution and is known to have edge-preserving properties (Bardsley, 2012). 
  
3. Methods 
3.1 Simulation experiments 
The proposed method was first tested using simulated image series as the parameter estimates can be 
compared to ground-truth values. The 6 by 6 voxel image series was created using ground truth tracer-
kinetic parameter maps with values as expected in the myocardium under three different realistic 
conditions mimicking a healthy patient at rest, a healthy patient at stress and a patient with stress-
inducible ischaemia (Broadbent et al., 2013). The parameter maps were used to forward simulate the 
model with a gamma-variate function used to generate a realistic AIF. The kinetic parameter values 
used in the simulation were 𝐹𝑏 = 3.5, 𝑣𝑝 = 0.08, 𝑣𝑒 = 0.16, 𝑃𝑆 = 1.0 in healthy voxels at stress and 𝐹𝑏 =
1.0, 𝑣𝑝 = 0.08, 𝑣𝑒 = 0.16, 𝑃𝑆 = 1.0 in healthy voxels at rest. The simulation phantom mimicking a patient 
with stress-inducible ischaemia was created using 𝐹𝑏 = 3.5, 𝑣𝑝 = 0.08, 𝑣𝑒 = 0.16, 𝑃𝑆 = 1.0  with two 
disconnected regions with reduced MBF (𝐹𝑏 = 1.0) added to mimic regions of stress-inducible 
myocardial ischaemia. Rician noise was added to the image, with the level chosen to achieve a realistic 
SNR of 15 (Broadbent et al., 2016; Cheng et al., 2007). The SNR here was defined to be the ratio of the 
standard deviation of the noise realisation to the maximum of the tissue curves. The data curves were 
simulated with a realistic temporal resolution of Δ𝑡 = 0.012 min, corresponding to a heart rate of 
roughly 83 beats per minute at stress and Δ𝑡 = 0.017 min at rest, for a total time 𝑇 = 3 min. The 
proposed parameter estimation method is compared in a Monte-Carlo study for 𝑛 = 20 distinct noise 
realisations, for each simulation phantom, with a traditional, gradient-based optimisation scheme in 
order to assess the accuracy and the reproducibility of the parameter estimates. The normalised mean 
square error (NMSE) between the true and estimated kinetic parameters is reported and a Mann-
Whitney U test is used to compare the distribution of the NMSE values from the Monte-Carlo study. A 
further assessment is conducted (also using the NMSE values) to compare the proposed hierarchical 
model to an equivalent non-hierarchical approach. 
 
 
3.2 In vivo experiments 
The technique was tested in eight patients suspected of having CAD referred for stress perfusion cardiac 
MRI at King’s College London. Image acquisition was performed on a 3.0T scanner (Philips Achieva-
TX, Philips Medical Systems) using standard acquisition protocols (Kramer et al., 2013). The typical 
acquisition parameters, TR/TE/flip angle/saturation prepulse delay were 2.5 ms/1.25 ms/15° /100 ms 
with a typical spatial resolution of 1.34 x 1.34 x 10 mm. The dynamic image series were acquired during 
first-pass injection of 0.075 mmol/kg Gadobutrol (Gadovist, Schering, Germany) at 4 ml/s followed by 
a 20 ml saline flush. A dual bolus contrast agent scheme was used to correct for signal saturation of the 
AIF, as previously described (Ishida et al., 2011). Images were acquired under adenosine-induced stress. 
The images were motion corrected using a previously validated scheme (Scannell et al., 2019).  
As aforementioned, a dual-bolus acquisition is performed in order to mitigate the difficulties caused by 
the non-linear relationship between the concentration of contrast agent and the MRI signal intensities. 
It is hence assumed there is a linear relationship between the concentration of contrast agent and the 
signal intensity.  The concentration of gadolinium (C(t)) was approximated from the signal intensities 
(S(t)) using an application specific version of the relative signal enhancement (Biglands et al., 2015; 
Ingrisch and Sourbron, 2013):  
                                                               𝐶(𝑡) =
1
𝑟1 ⋅ 𝑇1𝑏
(
𝑆(𝑡) − 𝑆(0)
𝑆𝐿𝑉(0)
)                                                            (8) 
with the 𝑇1𝑏 of blood taken as 1736 ms and 𝑟1 the contrast agent as 4.5 s
-1 mmol/L-1 (Broadbent et al., 
2016). S(0) is the average of the first five acquired images before the injection of contrast agent. 
Similarly, 𝑆𝐿𝑉(0) is the pre-contrast signal in the left ventricular blood pool. 
In the case of this patient data, there are no ground-truth parameter values to compare to. Therefore, the 
purpose of this study is to test whether the kinetic parameter values that are estimated can identify 
perfusion defects that match the visual assessment found in the clinical reports. This provides insight 
into the reliability of the fittings and the ability of the proposed method to deal with the more complex 
curves and error terms that are present in patient data. The number of failed fittings and outlier kinetic 
parameter estimates are further compared between implementations. All scans were reported blindly by 
experienced operators with level III CMR accreditation according to the guidelines of the Society for 
Cardiovascular Magnetic Resonance (SCMR). As per the expert assessment, four patients were 
classified as being positive for ischaemia and four were classified as not having obstructive coronary 
artery disease. The myocardium was contoured using the cvi42 software (Circle Cardiovascular Imaging 
Inc., Calgary, Alberta, Canada) by an experienced operator with level III CMR accreditation (SCMR) 
and the segmentations were exported using the open-source code of Bai et al. (Bai et al., 2017) 
3.3 Non-linear regression implementation 
All steps are implemented in Python, using the SciPy module for the optimisation (Jones et al., n.d.). 
The nonlinear regression approach uses the L-BFGS (Zhu et al., 1997) nonlinear optimisation scheme 
with box constraints. Each parameter was constrained to be within conservative physiological limits 
and to conform with what has been previously found with tracer-kinetic models (Broadbent et al., 2013). 
The parameters are constrained such that: 0.001 ≤ 𝐹𝑏 ≤ 6.0, 0.001 ≤ 𝑣𝑝 ≤ 0.3, 0.001 ≤ 𝑣𝑒 ≤ 0.4 and 
0.001 ≤ 𝑃𝑆 ≤ 4.0. This fitting is repeated 100 times with different initial conditions randomly chosen 
from a uniform distribution on each of these ranges (Romain et al., 2017). The reported parameter 
estimates are then the successful fit which has achieved the lowest cost function value. This is done to 
reduce the effect of the choice of the initial conditions on the parameter estimate and to minimise the 
risk of converging to local optima. A fit is defined as successful if it achieves a tolerance of less than 
10−8 within 1000 iterations and none of the resulting parameters achieve their upper or lower bounds. 
The AIF (𝐶𝐴𝐼𝐹(𝑡)) is extracted using independent component analysis (Jacobs et al., 2016) and the bolus 
arrival time is estimated using the method of Cheong et al (Cheong et al., 2003).  
3.4 Bayesian parameter estimation implementation 
The Bayesian parameter estimate was implemented using an in-house software developed in Python. 
The posterior distribution for the parameters in voxel 𝑖 is given through the application of Bayes’ 
theorem as:  
                                              𝑝(𝚯𝐢, 𝛂𝐢|𝒚𝒊) ∝  𝑝(𝐲𝐢|𝚯𝐢, 𝛂𝐢) ⋅ 𝑝(𝚯𝐢|𝛂𝐢) ⋅ 𝑝(𝛂𝐢)                                          (9) 
It is assumed that the observed data in voxel 𝑖 at time 𝑡𝑗 is Gaussian distributed, i.e that 
𝑦𝑖(𝑡𝑗) ~𝒩(𝐶𝚯𝐢(𝑡𝑗), 𝜎𝑖
2). This gives rise to the likelihood function:  
                                    𝑝(𝐲𝐢|𝚯𝐢, 𝛂𝐢) = (2𝜋𝜎𝑖
2)
−
𝑁
2 exp(−
1
2𝜎𝑖
2 ∑ (𝑦
𝑖(𝑡𝑗) − 𝐶𝚯𝐢(𝑡𝑗))
2
𝑁−1
𝑗=0
)                        (10) 
In this work, 𝐹𝑏 (mL/min/mL) is selected to be Gaussian distributed with mean 𝛼𝑝 and a fixed variance 
0.2. 𝑃𝑆 (mL/min/mL) is Gaussian distributed with mean 𝛼𝑆 and variance 0.1. 𝛼𝑝 is taken to be 
uniformly distributed on [0,7] and 𝛼𝑆 is taken to be uniformly distributed on [0,5]. 𝑣𝑝 (%/100) is 
assumed to be uniformly distributed on [0,0.4] and 𝑣𝑒 (%/100) is assumed to be uniformly distributed 
on [0,0.5]. These were chosen to be in line with previously reported literature values (Broadbent et al., 
2013) and physiological intuition. The priors are chosen to be weakly informative in that they 
encompass a much larger range of values than the values that have been found previously in the 
literature. Rather than expressing a confidence about the parameters close to a certain value, it restricts 
the parameter estimates to these ranges. The prior distribution on the observed error (in M) for voxel 𝑖 
(𝜎𝑖
2) is taken to be a flat Inverse-Gamma distribution, with shape parameter 𝑐 = 0.001 and scale 
parameter 𝑑 = 0.001, as is conventional.  
A Laplace prior with location 0 and scale 0.2 is chosen on the absolute value of the distance between 
the kinetic parameter estimates of neighbouring voxels. The Laplace distribution is chosen due to its 
edge preserving properties. This gives rise to the prior distribution: 
         𝑝(𝚯𝐢|𝛂𝐢) = 𝑝 (𝐹𝑝
𝑖|𝛼𝐹𝑝
𝑖 ) ⋅ 𝑝(𝑣𝑝
𝑖 ) ⋅ 𝑝(𝑣𝑒
𝑖) ⋅ 𝑝(𝑃𝑆𝑖|𝛼𝑃𝑆
𝑖 ) ⋅ 𝑝(𝜎𝑖
2) ⋅ 𝑝(𝚯𝐢|𝚯𝐧(𝐢), 𝛂𝐢, 𝜈𝑖,𝑗)  
∝  exp (−
1
2 ⋅ 0.1
(𝐹𝑝
𝑖 − 𝛼𝐹𝑝
𝑖 )
2
) × 𝕀(𝑣𝑝
𝑖 ∈ (0,0.3]) × 𝕀(𝑣𝑒
𝑖 ∈ (0,0.4]) ×  
exp (−
1
2 ⋅ 0.1
(𝑃𝑆𝑖 − 𝛼𝑃𝑆
𝑖 )
2
) × (
1
𝜎𝑖
2)
𝑐−1
exp(−
𝑑
𝜎𝑖
2) 
                                                           × exp (−
1
0.2
 ∑ ∑(𝑊𝑘 ⋅ |Θ𝑘
i − Θ𝑘
j
|)
4
𝑘=1𝑗∈𝑛(𝑖)
)                                         (11) 
𝕀(𝑋) is the indicator function on the set 𝑋 which takes the value 1 on 𝑋 and 0 otherwise. 𝑛(𝑖) is the set 
of neighbouring voxels of voxel 𝑖. A voxel’s neighbours are those voxels in its surrounding 4-
neighbourhood, above, below, to the left and to the right of it. Due to the shape of the myocardium, it 
is possible that a voxels neighbours are not in the myocardial segmentation. In such a case, a voxel 
diagonally above or below is taken or failing that, the closest voxel that is in the myocardium.   
The distance between the parameter estimates in neighbouring voxels 𝑖 and 𝑗 is computed using a 
weighted sum. The weights, 𝑊𝑘  are used to account for the different scales of the parameters, since 
otherwise, differences in the higher magnitude parameter values (𝐹𝑏 and 𝑃𝑆) would have a dominating 
effect compared to the lower magnitude parameter values (𝑣𝑝 and 𝑣𝑒). The value of the weight for a 
given parameter 𝑊𝑘 on a given iteration of the MCMC sampling is the inverse of the previous sample 
of the parameter. For the non-hierarchical model it is taken that 𝐹𝑏~𝒩(3.5, 0.2) and 𝑃𝑆~𝒩(1.0,0.2). 
The hyperprior distribution is given as: 
                                            𝑝(𝛂𝐢) =  𝕀 (𝛼𝐹𝑝
𝑖 ∈ [0.001,7]) × 𝕀(𝛼𝑃𝑆
𝑖 ∈ [0.001,5])                              (12) 
In this work, the Metropolis-Hasting algorithm with random walk proposals is used to sample from the 
posterior distribution. In short, the Metropolis-Hasting algorithm moves randomly through parameter 
space using a proposal distribution. The proposal distribution proposes a move in parameter space that 
is then accepted with a probability that is related to the change in posterior probability associated with 
the new sample. This leads to the construction of a Markov chain with a stationary distribution that 
approximates the posterior distribution.  
In the work, the choice of the above distributions and their respective variances was made, empirically, 
to optimise the trade-off between thoroughly exploring parameter space and sticking to areas with high 
posterior probability. They were chosen in order to achieve a rate of acceptance of proposals close to 
0.234 which has previously been shown to be optimal (Roberts et al., 1997). Markov chains of 4000 
steps were constructed. In order to assess the stationary distribution of the chain, the initial 1000 steps 
were discarded, referred to as the burn-in phase. The number of steps was chosen to be far in excess of 
the number needed for convergence according to the ?̂? statistic (Gelman and Rubin, 1992). In order to 
create parameter maps, the median value of the posterior distribution are reported and to examine the 
uncertainty associated with such a parameter estimate, the coefficient of variation of the posterior 
distribution, the ratio of the standard deviation of the distribution to its mean value, is reported.  
4. Results 
4.1 Simulations 
Table 1 shows the mean (standard deviation) NMSE between the estimated and true kinetic parameters 
values for both the hierarchical Bayesian and non-linear least squares implementations, with the results 
of the Mann-Whitney U-test. The NMSE is significantly lower for the Bayesian method compared to 
the non-linear least squares. Example parameter maps from both methods are compared to the true 
parameter maps in Fig. 3. A significantly higher NMSE was found using in the stress simulations with 
a perfusion defect using the non-hierarchical approach (0.24 (0.15), p < 0.001) with a comparison of 
the computed MBF parameter maps for an example noise realisation shown in Fig. 4.  
Table 1. 
Parameter Bayesian Non-linear least 
squares 
p-value 
Mann-Whitney U test 
All 0.13 (0.2) 0.32 (0.55) p < 0.0001 
𝐹𝑏 0.05 (0.09) 0.1 (0.09) p = 0.002 
𝑣𝑝 0.22 (0.27) 0.35 (0.31) p = 0.02 
𝑣𝑒 0.12 (0.16) 0.20 (0.17) p = 0.01 
PS 0.11 (0.21) 0.63 (0.96) p < 0.0001 
 
Table 1: NMSE and Mann-Whitney U test results for the hierarchical Bayesian and non-linear least 
squares kinetic parameter estimates. 
 
 
 
 
Figure 3. 
  
The ground-truth 𝐹𝑏 parameter values (left) are compared to values that are estimated using non-
linear least-squares fitting (middle), and the proposed Bayesian inference method (right) for two 
random noise realisations of the simulations mimicking stress-inducible ischaemia (top and middle) 
and one random noise realisation of the rest simulations (bottom). The Bayesian inference is 
significantly closer to the ground-truth with fewer outliers. 
Figure 4. 
        
 
The comparison between the hierarchical and non-hierarchical approach for an example noise 
realisation with the same ground-truth MBF maps at stress with a simulated perfusion defect as 
shown in Fig. 3. This shows the effect of using prior distributions with fixed means which influence 
the information from the data to drive the parameter estimate towards the prior value. 
 4.2 Patient data 
The median computed MBF value (25th percentile, 75th percentile) was 2.35 (1.9, 2.68) mL/min/mL 
under stress conditions using the proposed Bayesian inference scheme. The equivalent results were 2.37 
(1.12, 3.01) mL/min/mL using the non-linear least squares fitting. However, with the least squares 
fitting approach there is a number of voxels for which the fitting fails completely, which are represented 
as holes in the parameter maps, as seen in Fig. 5. The proposed Bayesian inference techniques has zero 
voxels with estimates converging to upper or lower bounds or outside physiological ranges. The least-
squares fitting fails for an average (standard deviation) of 12.9% (12.4%) of voxels per slice. 
Additionally, a MBF value of greater than 5 mL/min/mL (considered to be outliers) was found in 7.5% 
of voxels using least-squares fitting but never achieved with the Bayesian inference. The other kinetic 
parameter values are quoted in Table 2. The median (25th percentile, 75th percentile) coefficient of 
variation of the Bayesian posterior was 6.6% (3.3%, 11.7%). A maximum value of 87.7% was achieved 
with 0.8% of voxels having a parameter with a coefficient of variation greater than 50%. 
The assessment of the presence of coronary artery disease based purely on the quantitative flow maps 
obtained using Bayesian inference matches the visual assessment in all 24 slices. When using the maps 
obtained by the least-squares fitting, a corresponding assessment is achieved in 16/24 slices. The 
computed flow parameter maps under stress conditions for an example patient with a perfusion defect 
are shown in Fig. 5. The identified areas of ischaemia are indicated with a blue arrow in the original 
MR images. An example of a slice where the least-squares fitting fails to correspond to the visual 
assessment is shown in Fig. 6. The visual assessment concluded that there is reduced uptake of contrast 
agent in both the inferior and infero-septal segments. This clearly corresponds with the Bayesian 
inference. The least-squares fitting is extremely noisy and the ischaemic area is under-estimated in the 
inferior segment and almost completely missed in the infero-septum. Fig. 7. shows all four kinetic 
parameters (left column) with the coefficient of variation of the MCMC sample of the parameter 
posterior distribution (right column).   
 
Table 2. 
Parameter Bayesian Non-linear least squares 
𝐹𝑏 (mL/min/mL) 2.35 (1.9, 2.68)  2.37 (1.12, 3.01) 
𝑣𝑝 (%/100) 0.09 (0.05, 0.13) 0.07 (0.03, 0.13) 
𝑣𝑒 (%/100) 0.21 (0.13.0.31) 0.19 (0.12, 0.29) 
PS (mL/min/mL) 0.88 (0.59,1.45) 3.3 (0.61, 4.74) 
 
Table 2: Median (25th percentile, 75th percentile) kinetic parameter estimates, on the patient data, using 
the Bayesian inference and non-linear least squares fitting approaches.  
Figure 5. 
 
 A comparison of Bayesian inference versus least-squares fitting with 100 random initialisations for the 
three acquired slices for a patient with an overt perfusion defect (as indicated by the arrows in the first 
row). While both techniques identify the area of ischaemia the least-squares fittings have severe 
speckle-like noise and even gaps where the fitting has failed. This makes it more difficult to accurately 
delineate the boundaries of the ischaemic area and can lead to areas where the ischaemia is missed. 
Figure 6. 
 
An example slice where the Bayesian fitting (right) has correctly identified ischaemia but the noisy least 
squares fitting (middle) makes it difficult to identify the ischaemia, particularly in the infero-septal wall. 
The identified areas of ischaemia are indicated on the original MR image (left). 
Figure 7. 
 
Parameter maps for the four kinetic parameters of the 2CXM. The coefficient of variation represents 
the uncertainty about the parameter estimate and could be incorporated into the clinical decision 
making process. Black arrows are used to compare areas of high uncertainty to the respective 
parameter estimates.  
5. Discussion 
In this work, the use of Bayesian inference to estimate tracer-kinetic parameters from myocardial 
perfusion MRI data is investigated. This approach incorporates both spatial prior knowledge and prior 
knowledge on the kinetic parameter values. It also enables the computation of posterior distributions 
over the model parameters. It is compared to the more traditional method of parameter estimation, the 
non-linear least squares fitting. This comparison first assesses the accuracy and reproducibility of the 
parameter estimations in a simulated, but realistic, setting. The two methods are also compared using 
patient data to assess the success of disease detection using the quantitative flow maps. 
As discussed, a possible alternative approach is to use a simpler model for the quantitative modelling 
such as using a Fermi-constrained deconvolution (Jerosch-Herold et al., 1998; Zarinabad et al., 2012). 
The model to be fit to the data is simpler and has fewer parameters and thus can be fit more reliably, 
with less frequent failed fittings. However, such an approach only allows the resolution of MBF and 
the other parameters have no physiological interpretation. It is hypothesised that the extra physiological 
parameters that can be resolved using the two-compartment exchange model may allow a more 
informative assessment of the tissue. Tracer-kinetic models can also be fit more reliably on a segment-
wise level due to the reduced noise after the signal averaging. However, it has been shown that the 
reduction of spatial resolution leads to a loss of diagnostic information (Villa et al., 2016; Zarinabad et 
al., 2015). It is also likely that increasing the number of time points that are sampled may increase the 
reliability of the estimates but this may not be possible in a clinical setting. 
Lehnert et al. have also recently proposed the use of spatial regularisation (Lehnert et al., 2018). In this 
work, a Tikhonov (L2-norm) regularisation term is added to the cost function to be used in a gradient-
based optimisation process. However, this is known, and seen in this work, to introduce smoothing over 
physiological borders where a large difference in kinetic parameters occurs. In fact, in Kelm et al. (Kelm 
et al., 2009) it was shown that a L1-norm regularisation is more suitable in applications that possess 
sharp edges between kinetic parameters, such as myocardial perfusion MRI. This motivates the use of 
a Laplace prior in our work which is equivalent to L1-norm regularisation. The benefits of the Bayesian 
approach also include the use of the MCMC exploration of parameter space which is less susceptible to 
local optima than gradient-based optimisations. Bayesian inference also yields an approximation of the 
posterior distribution of the parameters rather than a point-estimate with no indication of uncertainty.  
Bayesian inference of tracer-kinetic parameters using DCE-MRI has been proposed previously (Dikaios 
et al., 2017; Orton et al., 2007; Schmid et al., 2006) and has in general been shown to be more reliable 
than non-linear least squares fitting. This work is however the first application to myocardial perfusion 
data, to our knowledge. The main innovation of this work is the utilisation of hierarchical priors. As 
discussed, hierarchical models allow model parameters to vary by group. The effect of using fixed priors 
is shown in Fig. 4. where the parameter estimates cannot adapt to areas that are largely different from 
the prior information (for example a perfusion defect).  In this application, this is desirable in order to 
avoid the averaging effects between areas of ischaemia and healthy myocardium without having to 
distinguish between the two groups a priori. Hierarchical modelling has been applied to DCE-MRI data 
by Schmid et al. (Schmid et al., 2009) in the setting of a clinical trial where two scans were acquired 
per patient, before and after treatment, leading to a temporal change in the kinetic parameters and thus 
two distinct groups of patients. This is different to our work which instead treats individual voxels in 
the spatial context as being from distinct groups, healthy or diseased. 
Using the simulations, it is found in this work that the Bayesian inference technique presented is 
significantly more accurate than the standard least-squares fitting as evidenced by the NMSE between 
the estimated and true parameter values. Furthermore, the variability of the estimates is reduced, as 
shown by the lower standard deviation and the estimates are more reproducible across different noise 
realisations. The benefit of using a hierarchical model is also demonstrated. It is seen that in the presence 
of areas of reduced MBF, the prior knowledge of stress MBF values does not apply and the non-
hierarchical model cannot account for the differences in groups of voxels (ischaemic and healthy). This 
leads to an averaging of the information from the data and the prior information and thus an over-
estimation of MBF in these areas. 
Naturally, there are no ground-truth values for comparison with the patient data estimates. However, 
the Bayesian parameter estimation leads to reduced numbers of outliers and failed fittings as compared 
to the least-squares fitting. The effect of this is shown in the parameter maps in Fig. 5. In this example, 
the perfusion defect in the inferior segment of the myocardium is clearly identified using both the 
Bayesian inference and least-squares fitting. However, there is still some speckle like noise present in 
the least-squares estimates, even after 100 repeated fittings. The noisy estimates can make it difficult to 
delineate the boundaries of the ischaemia and in this case lead to the underestimation of the extent of 
the ischaemia. It is clear from that the Bayesian inference is identifying correctly the area of reduced 
contrast uptake in the inferior segment, which is visible in the original MR image at the correct 
windowing level and is easily picked up when assessing the quantitative flow maps.  
These findings are in line with previous literature, Broadbent et al. (Broadbent et al., 2013) reported 
failed fittings in 10% of cases on a segment-wise level. This is despite the fact they considered curves 
which have been averaged over a segment of the myocardium to boost SNR. Schwab et al. (Schwab et 
al., 2015) reports a median flow value (25th percentile, 75th percentile) of 3.055 (1.197,1168.4) 
mL/min/mL using the 2CXM model with the conventional least-squares fitting approach. The 75th 
percentile value reported is well in excess of 100 times of the range of values that are physiologically 
feasible. Both the mean and 75th percentile are lower in the results we have presented, due to the bounds 
used in the optimiser in our implementation but we also found a number of failed fittings and outliers. 
Furthermore, in this work the 𝑃𝑆 values are extremely variable which could be due to the short 
acquisition period. Capillary permeability is known to affect the later part of the curves and this process 
may not be fully observed. This indicates the unreliability of conventional perfusion estimates and 
hence the difficulty of the clinical translation of quantitative perfusion analysis is apparent.  
Conversely, recent work, as presented by Kellman et al. (Kellman et al., 2017) has shown reproducible 
MBF values, using similar tracer-kinetic models, in a consistent population of healthy volunteers 
(Brown et al., 2018) and a good correlation with the MBF values derived from positron emission 
tomography (PET) (Engblom et al., 2017). However, this work did not present a new methodology for 
the model fitting and thus it is unclear how the fitting issues discussed here were addressed. 
Furthermore, this work has only considered the MBF and the other kinetic parameters are not validated. 
As our results in Fig. 2. show, due to parameter coupling it is impossible to judge the reliability of fitting 
by evaluating only a single parameter. We have demonstrated the ability to robustly infer the kinetic 
parameters and shown smoothness among all estimated parameters.  
The difficulty associated with the least-squares fitting is due to the complex nature of the cost function 
which can contain many local optima. The gradient-based optimisation schemes are susceptible to 
converging to the local minima and thus returning inaccurate parameter estimates. This problem is 
exacerbated by the relative complexity of the 2CXM relative to the observed data and the complex 
errors introduced by the imaging process. The result of this is the noisy and often inaccurate estimates 
seen in this study.  
Further well known issues with the standard least-squares fitting technique are that it is difficult to 
assess the uncertainty of the estimates and that these estimates are strongly dependent on the initial 
conditions of the optimisation process. The latter of these issues can be mitigated by using many 
randomly chosen initial positions but there is no structured or robust approach to doing this. These 
issues combine to limit the applicability of quantitative perfusion analysis in a clinical setting. Indeed, 
the patient data experiments show that the successful clinical classification of patients is worse with the 
least-squares fitting while perfect results are achieved with the Bayesian inference, albeit with a small 
sample size. The Bayesian inference does not depend on the initialisation of the optimisation as a burn-
in period is used and these sample values are discarded. Furthermore, it provides a natural framework 
for quantifying the uncertainty of the estimates through the computation of the a posteriori probability 
distribution of the parameters.   
In this work, using Bayesian inference, a median flow value (25th percentile, 75th percentile) of 2.35 
(1.9, 2.68) mL/min/mL is computed. The 25th and 75th percentile values are well within the range of 
what is physiologically feasible, showing the increased reliability of the parameter estimates obtained 
using Bayesian inference. Despite the fact that these studies have been conducted with different cohort 
of patients it still serves to show the significant improvement that is gained by employing a Bayesian 
inference approach to the parameter estimation.   
The coefficient of variation of the posterior distribution is used as a measure of uncertainty in the 
parameter estimate. The reported values indicate a reasonable level of confidence in the parameter 
estimates with the median coefficient of variation being 6.6%. However, higher coefficients of variation 
are also found, indicating high uncertainty in some regions. In Fig. 7., in the MBF parameter map (𝐹𝑏), 
it is seen that there is a high level of uncertainty at the border between the ischaemic and healthy regions 
(indicated by arrows). It makes sense that there more uncertainty in these border regions and it could 
possibly be as a result of conflicting information from its neighbouring voxels which could be either 
ischaemic or healthy. In the 𝑃𝑆 parameter map, there is also an isolated area of reduced permeability. 
However, it is seen to be associated with a high level of uncertainty. This uncertainty can be 
incorporated into an assessment of whether or not there is reduced capillary permeability here. Thus, 
this uncertainty measure may prove to be useful in the clinical decision-making process but further 
work on this topic is warranted. 
The improved results are due to the MCMC fitting, which better explores parameter space as compared 
to gradient-based methods, and the use of prior information. Prior information on the kinetic parameters 
acts as regularisation and constrains the parameter values to physiologically realistic ranges. The spatial 
prior information increases the amount of information used when fitting each voxel, enforces 
smoothness and reduces the speckle-like noise in the estimates. However, while spatial smoothness is 
enforced, it is seen in the figures that the parameter maps still preserves sharp change and there is not 
an over-smoothing of important physiological information.  
5. Limitations 
One of the main criticisms of MCMC algorithms is the large computational cost involved in accurately 
approximating the posterior distribution, though the use of multiple random initialisations in the least-
squares fitting is similarly computationally expensive. The computational cost could potentially be 
addressed using an efficient GPU-based implementation.  
A limitation of tracer-kinetic modelling, in general, is that the models used are simplified versions of 
the underlying processes. The aim of this work was to examine whether Bayesian inference can yield 
more reliable parameter estimates that non-linear least squares fitting with the 2CXM. There has been 
no effort made to investigate whether this is the most suitable model in this application 
There are no ground-truth parameter values for patient data and as such there is no way to comment 
directly on the accuracy of the parameter estimates. The absolute quantitative accuracy needs validation 
in comparison to a gold standard technique such as microspheres. Further work is also required on the 
clinical utility of the findings. In this work, diagnostic accuracy is only compared with the expert clinical 
assessment, however future work will involve comparisons with the gold standard examinations, 
invasive coronary angiography and fractional flow reserve, in a larger patient cohort. 
6. Conclusion  
Tracer-kinetic parameters can be accurately and robustly inferred from myocardial perfusion MRI using 
hierarchical Bayesian inference. The use of a MCMC fitting scheme and the inclusion of spatial prior 
knowledge improves the reliability of the parameter estimation as compared with least-squares fitting. 
As a result of the improved model fitting, the diagnostic capabilities of the technique is increased. 
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Appendix 
A.1 Residue function 
The pair of coupled differential equations (1), (2) can be solved analytically using the Laplace transform 
to yield a solution in the form:  
𝐶𝚯(𝑡) = 𝑅𝐹(𝑡, 𝚯) ∗ 𝐶𝐴𝐼𝐹(𝑡 − 𝜏0) 
 The residue function 𝑅𝐹 is given as: 𝑅𝐹(𝑡, 𝚯) = 𝐴 exp(𝛼𝑡) + (1 − 𝐴) exp(𝛽𝑡), where: 
𝛼, 𝛽 =
1
2
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